Abstract
Many oncology centers provide integrative oncology (IO) care, many within palliative care settings. The primary study objective was to examine the impact of IO-palliative patient-tailored program on quality of life (QoL) among patients with advanced cancer. In this pragmatic prospective controlled study, patients with advanced cancer undergoing chemotherapy/palliative care were referred by their oncology healthcare providers to an integrative physician (IP) consultation and weekly IO treatments. Patients with high adherence to integrative care (AIC; ≥ 4 IO sessions/6 weeks) were compared with moderate (2–3 sessions) or low AIC patients (regarded as control group). Outcomes were assessed at 6- and 12-week follow-up with Edmonton Symptom Assessment Scale (ESAS) and EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) tools. Change in QoL scores (ESAS fatigue in particular) was considered a primary study outcome. Of 225 eligible patients, 153 underwent baseline and 6-week optimal assessment (high AIC, 100; moderate AIC, 22; low AIC, 31). High AIC patients reported greater improvement on ESAS scores for fatigue (vs. low–moderate AIC, P < 0.001), depression (vs. moderate AIC, P = 0.01) at 6 weeks, and sleep (P = 0.007) at 12 weeks. High AIC patients had significantly improved EORTC global health status/QoL at 6 weeks (vs. moderate–low AIC, P = 0.01), cognitive functioning (vs. moderate AIC, P = 0.043), and social functioning (vs. moderate AIC, P = 0.032). High AIC patients had lower rates of hospitalizations at 12 weeks (19% vs. 35% in low AIC, P = 0.02; 44% in moderate AIC, P = 0.003), hospitalization days (vs. low AIC, P = 0.003), and opioid use (vs. low AIC, P < 0.001). High adherence to integrative care was associated with a significant effect on fatigue, depression, global QoL at 6 weeks, and need for hospitalizations at 12 weeks.
Similar content being viewed by others
References
Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, Kücük Ö, Mailman J, Mao JJ. A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. 2017. https://doi.org/10.1093/jncimonographs/lgx012.
Frenkel M, Sapire K, Lacey J, Sierpina VS. Integrative medicine: adjunctive element or essential ingredient in palliative and supportive cancer care? J Altern Complement Med. 2020;26(9):779–83. https://doi.org/10.1089/acm.2019.0316.
Zick SM, Sen A, Hassett AL, Schrepf A, Wyatt GK, Murphy SL, Arnedt JT, Harris RE. Impact of self-acupressure on co-occurring symptoms in cancer survivors. JNCI Cancer Spectr. 2018;2(4):pky064. https://doi.org/10.1093/jncics/pky064.
Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018;36(25):2647–55. https://doi.org/10.1200/JCO.2018.79.2721.
Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P. Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol. 2016;34(15):1795–802. https://doi.org/10.1200/JCO.2015.63.2893.
Segev Y, Lavie O, Stein N, Saliba W, Samuels N, Shalabna E, Raz OG, Schiff E, Ben-Arye E. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer. Support Care Cancer. 2021. https://doi.org/10.1007/s00520-020-05961-5.
Ben-Arye E, Schiff E, Shapira C, Frenkel M, Shalom T, Steiner M. Modeling an integrative oncology program within a community-centered oncology service in Israel. Patient Educ Couns. 2012;89(3):423–9.
Bruera E, Kuehn N, Miller M, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9.
Oldenmenger W, de Raaf P, de Klerk C, van der Rijt C. Cut points on 0–10 numeric rating scales for symptoms included in the Edmonton symptom assessment scale in cancer patients: a systematic review. J Pain Symp Manag. 2012. https://doi.org/10.1016/j.jpainsymman.2012.06.007.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.
Evans CJ, Harding R, Higginson IJ, MORECare. ‘Best practice’ in developing and evaluating palliative and end-of-life care services: a meta-synthesis of research methods for the MORECare project. Palliat Med. 2013;27(10):885–98. https://doi.org/10.1177/0269216312467489.
Julião M, Sobral MA, Calçada P, Antunes B, Nunes B, Bragança A, Runa D, Faria de Sousa P, Chochinov HM, Bruera E. “Truly holistic?” Differences in documenting physical and psychosocial needs and hope in Portuguese palliative patients. Palliat Support Care. 2020. https://doi.org/10.1017/S1478951520000413.
Hui D, Hannon BL, Zimmermann C, Bruera E. Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin. 2018;68(5):356–76. https://doi.org/10.3322/caac.21490.
Kerner H, Samuels N, Ben Moshe S, Sharabi IS, Ben-Arye E. Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy. BMJ Support Palliat Care. 2020;10(3): e21. https://doi.org/10.1136/bmjspcare-2017-001351.
Ben-Arye E, Dahan O, Shalom-Sharabi I, Samuels N. Inverse relationship between reduced fatigue and severity of anemia in oncology patients treated with integrative medicine: understanding the paradox. Support Care Cancer. 2018;26(12):4039–48.
Shalom-Sharabi I, Samuels N, Lavie O, Lev E, Keinan-Boker L, Schiff E, Ben-Arye E. Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer. J Cancer Res Clin Oncol. 2017;143(7):1243–54. https://doi.org/10.1007/s00432-017-2368-8.
Ben-Arye E, Elly D, Samuels N, Gressel O, Shulman K, Schiff E, Lavie O, Minerbi A. Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care. J Cancer Res Clin Oncol. 2021. https://doi.org/10.1007/s00432-020-03506-1.
Shalom-Sharabi I, Samuels N, Lev E, Lavie O, Keinan-Boker L, Schiff E, Ben-Arye E. Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications. Support Care Cancer. 2017;25(10):3181–90.
Acknowledgements
We would like to thank Mr. Yossi Heymann and the Eshel Joint Israel and the Division of Geriatrics, Israeli Ministry of Health, for their financial support through a research grant for the research project “Improving palliative care by a cross-cultural integrative medicine approach tailored to Arab- and Russian-speaking patients’ preferences on the continuum from the oncology ward to home hospice.” We would also like to thank Dr. Irit Laxer and the National Project for Palliative Care and End of Life Situations, Israel Ministry of Health.
Funding
National Project for Palliative Care and End of Life Situations, Israel Ministry of Health (Grant No. 00-3-2018).
Author information
Authors and Affiliations
Contributions
EB-A: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, drafting the article and revising it critically for important content, and final approval of the version to be submitted. YY: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, drafting the article and revising it critically for important content, and final approval of the version to be submitted. NS: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, drafting the article and revising it critically for important content, and final approval of the version to be submitted. OG: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, revising the article critically for important content, and final approval of the version to be submitted. AY: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, revising the article critically for important content, and final approval of the version to be submitted. ES: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, revising the article critically for important content, and final approval of the version to be submitted. MO: Conception and design of the study, drafting the article and revising it critically for important content, and final approval of the version to be submitted. WS: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, revising the article critically for important content, and final approval of the version to be submitted. JD: Conception and design of the study, acquisition of the data, analysis and interpretation of the data, revising the article critically for important content, and final approval of the version to be submitted.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ben-Arye, E., Yakubov, Y., Samuels, N. et al. Impact of a combined integrative oncology and palliative care program on quality of life of patients with advanced cancer. Med Oncol 38, 93 (2021). https://doi.org/10.1007/s12032-021-01544-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-021-01544-4